Provenienza dei contatti di primo grado di Myra Rosario Herrle
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
122
| Public Company | Pharmaceuticals: Major | 122 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ.
73
| Subsidiary | Pharmaceuticals: Major | 73 |
42
| Public Company | Pharmaceuticals: Major | 42 |
26
| Public Company | Pharmaceuticals: Major | 26 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Myra Rosario Herrle tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
POINT Biopharma, Inc. (United States)
 POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Miscellaneous Commercial Services | Chairman Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member Chief Executive Officer Chief Operating Officer Director/Board Member Director of Finance/CFO Corporate Officer/Principal | |
| University of Cambridge | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Genelabs Technologies, Inc.
 Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chairman Director/Board Member Director of Finance/CFO | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Oxford | College/University | Doctorate Degree Director/Board Member Undergraduate Degree Doctorate Degree Doctorate Degree | |
| University of Bristol | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO President Corporate Officer/Principal | |
| DICE THER | Biotechnology | President Director/Board Member Director/Board Member Corporate Secretary | |
POINT Biopharma Corp.
 POINT Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma Corp. is a Canadian company that develops next-generation radiopharmaceuticals for the treatment of cancer. The company is based in Toronto, Canada. POINT Biopharma develops radioligands, which are microscopic, cancer-seeking missiles used to diagnose and treat cancers such as non-Hodgkin's lymphoma and neuroendocrine tumors (NETs). To learn more about the company, interested parties can register online at https\://hub.pointbiopharma.com/investor-day-june-2023. The company was founded by Joe McCann. Joe McCann has been the CEO since incorporation. | Miscellaneous Commercial Services | Chairman Director/Board Member Chief Tech/Sci/R&D Officer Founder | |
| University of Toronto | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Corporate Officer/Principal | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| University of Michigan | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| INTERMUNE INC | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Sales & Marketing | |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | President Corporate Officer/Principal Sales & Marketing | |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Director/Board Member Chairman Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| University of London | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
| SIGILON THERAPEUTICS, INC. | Biotechnology | President Director/Board Member Corporate Secretary | |
| University of Wisconsin | College/University | Corporate Officer/Principal Masters Business Admin Doctorate Degree | |
| MERUS N.V. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Sales & Marketing | |
| BP PLC | Integrated Oil | Director/Board Member Director/Board Member Director/Board Member | |
The University of Liverpool
 The University of Liverpool Other Consumer ServicesConsumer Services The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom. | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| University of the Sciences in Philadelphia | College/University | Undergraduate Degree Director/Board Member Undergraduate Degree | |
| ACHILLION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | Private Equity Investor President President | |
| Stanford University | College/University | Masters Business Admin Corporate Officer/Principal Doctorate Degree | |
| The University of North Carolina at Charlotte | College/University | Corporate Officer/Principal Graduate Degree | |
| Philadelphia College of Osteopathic Medicine | College/University | Doctorate Degree Corporate Officer/Principal | |
Ethicon Corp.
 Ethicon Corp. Medical SpecialtiesHealth Technology Ethicon Corp. manufactures and markets surgical sutures. The company is headquartered in Somerville, NJ. | Medical Specialties | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| VODAFONE GROUP PLC | Wireless Telecommunications | Chief Executive Officer Director/Board Member | |
| Yale School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| LONZA GROUP AG | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Investor Relations Contact Corporate Officer/Principal | |
| RIO TINTO PLC | Other Metals/Minerals | Chairman Director/Board Member | |
| JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director of Finance/CFO Chief Operating Officer | |
International AIDS Vaccine Initiative, Inc.
 International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Corporate Officer/Principal | |
| ABBOTT LABORATORIES | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
| DIAGEO PLC | Beverages: Alcoholic | Director/Board Member Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| CELLECTIS S.A. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| University of Illinois | College/University | Undergraduate Degree Undergraduate Degree | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
Astra Merck, Inc.
 Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal |
Statistiche
Distribuzione geografica
| Stati Uniti | 33 |
| Regno Unito | 12 |
| Canada | 3 |
| Svizzera | 3 |
| Paesi Bassi | 2 |
Settori
| Health Technology | 26 |
| Consumer Services | 17 |
| Commercial Services | 4 |
| Finance | 3 |
| Energy Minerals | 2 |
Posizioni
| Director/Board Member | 476 |
| Corporate Officer/Principal | 233 |
| Independent Dir/Board Member | 168 |
| Chairman | 158 |
| Chief Tech/Sci/R&D Officer | 91 |
Contatti più connessi
| Insiders | |
|---|---|
| Argeris Karabelas | 42 |
| Richard Sykes | 37 |
| Russell Greig | 31 |
| David Epstein | 29 |
| Jean-Pierre Garnier | 28 |
| Faheem Hasnain | 27 |
| Deryck Charles Maughan | 27 |
| Mark Iwicki | 26 |
| Jonathan Goodman | 25 |
| Maxine Gowen | 23 |
| George Poste | 21 |
| H. Culp | 21 |
| Michael Owen | 20 |
| Crispin Davis | 20 |
| Christopher Gent | 19 |
- Borsa valori
- Insiders
- Myra Rosario Herrle
- Connessioni Società
